📋 Tender Overview
Project Number
609281
Sponsor
Ingenix.AI Ltd.
Date SCCP Disclosed
May 27, 2025
Country
Poland
Region
Europe
Last Updated Date
Industry
Disruptive Technologies & Funds
Sector
S-A - Hospitals, Clinics, Laboratories & Other
Department
Disruptive Tech, Service & Funds
Project Summary
IFC is partnering with the deep tech startup Ingenix.AI LTD (Ingenix, or the Company) to support the development of an AI-powered clinical trial simulations solution that helps pharmaceutical companies de-risk clinical trials, improve efficiency, and bring new treatments to patients faster. With traditional drug development facing significant challenges, AI-driven simulations can help streamline the process, reduce uncertainty, and optimize resources. This investment aligns with IFC’s digital health strategy, and the collaboration will aim to support Ingenix with product feasibility and commercialization efforts to ensure that emerging markets can also benefit from cutting-edge healthcare innovations.
E & S Information
This is a Category C project according to Policy on Social and Environmental Sustainability, as IFC’s environmental and social (E&S) due diligence indicates that the project involves a low level of E&S risk considering Ingenix develops an advanced generative AI product for clinical drug development, where Ingenix’s product is only used as a productivity software that does not interact with clinical trial subjects. Key E&S risks and issues are minimal and include: (i) the E&S policies and procedures; (ii) labor and working conditions; and (iii) emergency preparedness and response at the company’s leased office. Ingenix’s operations are managed in compliance with Polish laws and regulations. Ingenix will develop and implement an Environmental and Social Management System (ESMS) that includes documented E&S policies and procedures including sexual harassment and gender-based violence policies and worker’s grievance mechanism procedure, worker’s health and safety trainings (e.g., ergonomics). IFC will require Ingenix to implement these policies and procedures consistently and to report any significant E&S incidents